BioScience Health Innovations 3Q 2026: Revenue $970.07K, EPS ($0.01) — 10-Q Summary
BioScience Health Innovations reported 3Q 2026 revenue of $970.07K, down 14% YoY, and a net loss of $149,225, wider than the prior year's $8,782. Operating expenses increased to $785,824 due to exchange-listing costs, marketing, R&D, and other factors. Management remains confident in projected growth.
